• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

John V. Frangioni, MD, PhD


  • Tummers QR, Verbeek FP, Prevoo HA, Braat AE, Baeten CI, Frangioni JV, van de Velde CJ, Vahrmeijer AL.First Experience on Laparoscopic Near-Infrared Fluorescence Imaging of Hepatic Uveal Melanoma Metastases Using Indocyanine Green.Surg Innov. 2014 Jun 5.
  • Ashitate Y, Hyun H, Kim SH, Lee JH, Henary M, Frangioni JV, Choi HS.Simultaneous mapping of pan and sentinel lymph nodes for real-time image-guided surgery.Theranostics. 2014;4(7):693-700.
  • Verbeek FP, van der Vorst JR, Tummers QR, Boonstra MC, de Rooij KE, Löwik CW, Valentijn AR, van de Velde CJ, Choi HS, Frangioni JV, Vahrmeijer AL.Near-Infrared Fluorescence Imaging of Both Colorectal Cancer and Ureters Using a Low-Dose Integrin Targeted Probe.Ann Surg Oncol. 2014 Feb 11.
  • Verbeek FP, Troyan SL, Mieog JS, Liefers GJ, Moffitt LA, Rosenberg M, Hirshfield-Bartek J, Gioux S, van de Velde CJ, Vahrmeijer AL, Frangioni JV.Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience.Breast Cancer Res Treat. 2014 Jan;143(2):333-42.
  • van der Vorst JR, Schaafsma BE, Verbeek FP, Swijnenburg RJ, Tummers QR, Hutteman M, Hamming JF, Kievit J, Frangioni JV, van de Velde CJ, Vahrmeijer AL.Intraoperative near-infrared fluorescence imaging of parathyroid adenomas with use of low-dose methylene blue.Head Neck. 2013 May 29.
  • van der Vorst JR, Schaafsma BE, Hutteman M, Verbeek FP, Liefers GJ, Hartgrink HH, Smit VT, Löwik CW, van de Velde CJ, Frangioni JV, Vahrmeijer AL.Near-infrared fluorescence-guided resection of colorectal liver metastases.Cancer. 2013 Sep 15;119(18):3411-8.
  • Gilmore DM, Khullar OV, Jaklitsch MT, Chirieac LR, Frangioni JV, Colson YL.Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using near-infrared imaging.J Thorac Cardiovasc Surg. 2013 Sep;146(3):562-70; discussion 569-70.
  • Schaafsma B, Verbeek F, Peters A, van der Vorst J, de Kroon C, van Poelgeest M, Trimbos J, van de Velde C, Frangioni J, Vahrmeijer A, Gaarenstroom K.Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers.BJOG. 2013 May;120(6):758-764.
  • Verbeek FP, van der Vorst JR, Schaafsma BE, Swijnenburg RJ, Gaarenstroom KN, Elzevier HW, van de Velde CJ, Frangioni JV, Vahrmeijer AL.Intraoperative Near-Infrared Fluorescence-Guided Identification of the Ureters using Low-Dose Methylene Blue: A First-in-Human Experience.J Urol. 2013 Mar 1.
  • Gilmore DM, Khullar OV, Gioux S, Stockdale A, Frangioni JV, Colson YL, Russell SE.Effective Low-dose Escalation of Indocyanine Green for Near-infrared Fluorescent Sentinel Lymph Node Mapping in Melanoma.Ann Surg Oncol. 2013 Feb 26.
  • Schaafsma BE, Verbeek FP, van der Vorst JR, Hutteman M, Kuppen PJ, Frangioni JV, van de Velde CJ, Vahrmeijer AL.Ex vivo sentinel node mapping in colon cancer combining blue dye staining and fluorescence imaging.J Surg Res. 2013 Jan 25.
  • Choi HS, Gibbs SL, Lee JH, Kim SH, Ashitate Y, Liu F, Hyun H, Park G, Xie Y, Bae S, Henary M, Frangioni JV.Targeted zwitterionic near-infrared fluorophores for improved optical imaging.Nat Biotechnol. 2013 Jan 6;31(2):148-53.
  • Nguyen JT, Ashitate Y, Buchanan IA, Ibrahim AM, Gioux S, Patel PP, Frangioni JV, Lee BT.Bone flap perfusion assessment using near-infrared fluorescence imaging.J Surg Res. 2012 Dec;178(2):e43-50.
  • Frangioni JV.Nonprofit foundations for open-source biomedical technology development.Nat Biotechnol. 2012 Oct 10;30(10):928-32.
  • Hyun H, Bordo MW, Nasr K, Feith D, Lee JH, Kim SH, Ashitate Y, Moffitt LA, Rosenberg M, Henary M, Choi HS, Frangioni JV.cGMP-Compatible preparative scale synthesis of near-infrared fluorophores.Contrast Media Mol Imaging.;7(6):516-24.
  • Ashitate Y, Vooght CS, Hutteman M, Oketokoun R, Choi HS, Frangioni JV.Simultaneous assessment of luminal integrity and vascular perfusion of the gastrointestinal tract using dual-channel near-infrared fluorescence.Molecular Imaging.;11(4):301-8.
  • van der Vorst JR, Schaafsma BE, Verbeek FP, Keereweer S, Jansen JC, van der Velden LA, Langeveld AP, Hutteman M, Löwik CW, van de Velde CJ, Frangioni JV, Vahrmeijer AL.Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients.Oral Oncol. 2012 Aug 28.
  • Schaafsma BE, van der Vorst JR, Gaarenstroom KN, Peters AA, Verbeek FP, de Kroon CD, Trimbos JB, van Poelgeest MI, Frangioni JV, van de Velde CJ, Vahrmeijer AL.Randomized comparison of near-infrared fluorescence lymphatic tracers for sentinel lymph node mapping of cervical cancer.Gynecol Oncol. 2012 Oct;127(1):126-30.
  • van der Vorst JR, Vahrmeijer AL, Hutteman M, Bosse T, Smit VT, van de Velde CJ, Frangioni JV, Bonsing BA.Near-infrared fluorescence imaging of a solitary fibrous tumor of the pancreas using methylene blue.World J Gastrointest Surg. 2012 Jul 27;4(7):180-4.
  • Bhatia S, Frangioni JV, Hoffman RM, Iafrate AJ, Polyak K.The challenges posed by cancer heterogeneity.Nat Biotechnol. 2012 Jul;30(7):604-10.
  • Ashitate Y, Kim SH, Tanaka E, Henary M, Choi HS, Frangioni JV, Flaumenhaft R.Two-wavelength near-infrared fluorescence for the quantitation of drug antiplatelet effects in large animal model systems.J. Vasc. Surg. 2012 Jul;56(1):171-80.
  • van der Vorst JR, Schaafsma BE, Verbeek FP, Hutteman M, Mieog JS, Lowik CW, Liefers GJ, Frangioni JV, van de Velde CJ, Vahrmeijer AL.Randomized Comparison of Near-infrared Fluorescence Imaging Using Indocyanine Green and 99(m) Technetium With or Without Patent Blue for the Sentinel Lymph Node Procedure in Breast Cancer Patients.Ann Surg Oncol. 2012 Jul 3.
  • Liu F, Lunsford EP, Tong J, Ashitate Y, Gibbs SL, Yu J, Choi HS, Henske EP, Frangioni JV.Real-time monitoring of tumorigenesis, dissemination, & drug response in a preclinical model of lymphangioleiomyomatosis/tuberous sclerosis complex.PLoS ONE. 2012;7(6):e38589.
  • Orcutt KD, Rhoden JJ, Ruiz-Yi B, Frangioni JV, Wittrup KD.Effect of small-molecule-binding affinity on tumor uptake in vivo: a systematic study using a pretargeted bispecific antibody.Mol Cancer Ther. 2012 Jun;11(6):1365-72.
  • Frangioni JV.The myth of multimodality diagnostic agents.Mol Imaging. 2011 Apr;10(2):79-80.
  • van der Vorst JR, Hutteman M, Mieog JS, de Rooij KE, Kaijzel EL, Löwik CW, Putter H, Kuppen PJ, Frangioni JV, van de Velde CJ, Vahrmeijer AL.Near-Infrared Fluorescence Imaging of Liver Metastases in Rats using Indocyanine Green.J Surg Res. 2011 Feb 2.
  • Hutteman M, Choi HS, Mieog JS, van der Vorst JR, Ashitate Y, Kuppen PJ, van Groningen MC, Löwik CW, Smit VT, van de Velde CJ, Frangioni JV, Vahrmeijer AL.Clinical translation of ex vivo sentinel lymph node mapping for colorectal cancer using invisible near-infrared fluorescence light.Ann Surg Oncol. 2011 Apr;18(4):1006-14.
  • Mieog JS, Troyan SL, Hutteman M, Donohoe KJ, van der Vorst JR, Stockdale A, Liefers GJ, Choi HS, Gibbs-Strauss SL, Putter H, Gioux S, Kuppen PJ, Ashitate Y, Löwik CW, Smit VT, Oketokoun R, Ngo LH, van de Velde CJ, Frangioni JV, Vahrmeijer AL.Toward Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer.Ann Surg Oncol. 2011 Mar 1.
  • Hutteman M, Mieog JS, van der Vorst JR, Liefers GJ, Putter H, Löwik CW, Frangioni JV, van de Velde CJ, Vahrmeijer AL.Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients.Breast Cancer Res Treat. 2011 Mar 1.
  • Orcutt KD, Slusarczyk AL, Cieslewicz M, Ruiz-Yi B, Bhushan KR, Frangioni JV, Wittrup KD.Engineering an antibody with picomolar affinity to DOTA chelates of multiple radionuclides for pretargeted radioimmunotherapy and imaging.Nucl Med Biol. 2011 Feb;38(2):223-33.
  • Mazhar A, Dell S, Cuccia DJ, Gioux S, Durkin AJ, Frangioni JV, Tromberg BJ.Wavelength optimization for rapid chromophore mapping using spatial frequency domain imaging.J Biomed Opt.;15(6):061716.
  • Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, Bawendi MG, Semmler-Behnke M, Frangioni JV, Tsuda A.Rapid translocation of nanoparticles from the lung airspaces to the body.Nat Biotechnol. 2010 Dec;28(12):1300-3.
  • Choi HS, Frangioni JV.Nanoparticles for biomedical imaging: fundamentals of clinical translation.Mol Imaging. 2010 Dec;9(6):291-310.
  • Lee BT, Hutteman M, Gioux S, Stockdale A, Lin SJ, Ngo LH, Frangioni JV.The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in perforator flap breast reconstruction.Plast Reconstr Surg. 2010 Nov;126(5):1472-81.
  • Matsui A, Lee BT, Winer JH, Laurence RG, Frangioni JV.Predictive capability of near-infrared fluorescence angiography in submental perforator flap survival.Plast Reconstr Surg. 2010 Nov;126(5):1518-27.
  • Gioux S, Choi HS, Frangioni JV.Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation.Mol Imaging. 2010 Oct;9(5):237-55.
  • Zubris KA, Khullar OV, Griset AP, Gibbs-Strauss S, Frangioni JV, Colson YL, Grinstaff MW.Ease of synthesis, controllable sizes, and in vivo large-animal-lymph migration of polymeric nanoparticles.ChemMedChem. 2010 Sep 3;5(9):1435-8.
  • Matsui A, Tanaka E, Choi HS, Kianzad V, Gioux S, Lomnes SJ, Frangioni JV.Real-time, near-infrared, fluorescence-guided identification of the ureters using methylene blue.Surgery. 2010 Jul;148(1):78-86.
  • Liu F, Misra P, Lunsford EP, Vannah JT, Liu Y, Lenkinski RE, Frangioni JV.A dose- and time-controllable syngeneic animal model of breast cancer microcalcification.Breast Cancer Res Treat. 2010 Jul;122(1):87-94.
  • Orcutt KD, Nasr KA, Whitehead DG, Frangioni JV, Wittrup KD.Biodistribution and Clearance of Small Molecule Hapten Chelates for Pretargeted Radioimmunotherapy.Mol Imaging Biol. 2010 Jun 9.
  • Schulz MD, Khullar O, Frangioni JV, Grinstaff MW, Colson YL.Nanotechnology in thoracic surgery.Ann Thorac Surg. 2010 Jun;89(6):S2188-90.
  • Orcutt KD, Ackerman ME, Cieslewicz M, Quiroz E, Slusarczyk AL, Frangioni JV, Wittrup KD.A modular IgG-scFv bispecific antibody topology.Protein Eng. Des. Sel. 2010 Apr;23(4):221-8.
  • Winer JH, Choi HS, Gibbs-Strauss SL, Ashitate Y, Colson YL, Frangioni JV.Intraoperative localization of insulinoma and normal pancreas using invisible near-infrared fluorescent light.Ann Surg Oncol. 2010 Apr;17(4):1094-100.
  • Mazhar A, Cuccia DJ, Gioux S, Durkin AJ, Frangioni JV, Tromberg BJ.Structured illumination enhances resolution and contrast in thick tissue fluorescence imaging.J Biomed Opt.;15(1):010506.
  • Kesavan K, Ratliff J, Johnson EW, Dahlberg W, Asara JM, Misra P, Frangioni JV, Jacoby DB.Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.J Biol Chem. 2010 Feb 12;285(7):4366-74.
  • Lee BT, Matsui A, Hutteman M, Lin SJ, Winer JH, Laurence RG, Frangioni JV.Intraoperative near-infrared fluorescence imaging in perforator flap reconstruction: current research and early clinical experience.J Reconstr Microsurg. 2010 Jan;26(1):59-65.
  • Gioux S, Ashitate Y, Hutteman M, Frangioni JV.Motion-gated acquisition for in vivo optical imaging.J Biomed Opt.;14(6):064038.
  • Choi HS, Liu W, Liu F, Nasr K, Misra P, Bawendi MG, Frangioni JV.Design considerations for tumour-targeted nanoparticles.Nat Nanotechnol. 2010 Jan;5(1):42-7.
  • Frangioni JV.The problem is background, not signal.Mol Imaging. 2009 Dec;8(6):303-4.
  • Matsui A, Lee BT, Winer JH, Laurence RG, Frangioni JV.Submental perforator flap design with a near-infrared fluorescence imaging system: the relationship among number of perforators, flap perfusion, and venous drainage.Plast Reconstr Surg. 2009 Oct;124(4):1098-104.
  • Troyan SL, Kianzad V, Gibbs-Strauss SL, Gioux S, Matsui A, Oketokoun R, Ngo L, Khamene A, Azar F, Frangioni JV.The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping.Ann Surg Oncol. 2009 Oct;16(10):2943-52.
  • Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, Spiegelman BM.Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex.Nature. 2009 Aug 27;460(7259):1154-8.
  • Matsui A, Lee BT, Winer JH, Kianzad V, Frangioni JV.Image-guided perforator flap design using invisible near-infrared light and validation with x-ray angiography.Ann Plast Surg. 2009 Sep;63(3):327-30.
  • Matsui A, Lee BT, Winer JH, Laurence RG, Frangioni JV.Quantitative assessment of perfusion and vascular compromise in perforator flaps using a near-infrared fluorescence-guided imaging system.Plast Reconstr Surg. 2009 Aug;124(2):451-60.
  • Tanaka E, Chen FY, Flaumenhaft R, Graham GJ, Laurence RG, Frangioni JV.Real-time assessment of cardiac perfusion, coronary angiography, and acute intravascular thrombi using dual-channel near-infrared fluorescence imaging.J Thorac Cardiovasc Surg. 2009 Jul;138(1):133-40.
  • Choi HS,Ipe BI,Misra P,Lee JH,Bawendi MG,Frangioni JV.Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots.Nano Lett. 2009 Jun;9(6):2354-9.
  • Matsui A,Lomnes SJ,Frangioni JV.Optical clearing of the skin for near-infrared fluorescence image-guided surgery.J Biomed Opt. 2009 Mar-Apr;14(2):024019.
  • Pannier N,Humblet V,Misra P,Frangioni JV,Maison W.Multivalent peptidomimetics for tumor targeting.Adv Exp Med Biol. 2009;611:403-4.
  • Matsui A,Lee BT,Winer JH,Vooght CS,Laurence RG,Frangioni JV.Real-time intraoperative near-infrared fluorescence angiography for perforator identification and flap design.Plast Reconstr Surg. 2009 Mar;123(3):125e-7e.
  • Ciocan R,Lenkinski RE,Bernstein J,Bancu M,Marquis R,Ivanishev A,Kourtelidis F,Matsui A,Borenstein J,Frangioni JV.MRI contrast using solid-state, B1-distorting, microelectromechanical systems (MEMS) microresonant devices (MRDs).Magn Reson Med. 2009 Apr;61(4):860-6.
  • Humblet V,Misra P,Bhushan KR,Nasr K,Ko YS,Tsukamoto T,Pannier N,Frangioni JV,Maison W.Multivalent scaffolds for affinity maturation of small molecule cell surface binders and their application to prostate tumor targeting.J Med Chem. 2009 Jan 22;52(2):544-50.
  • Bhushan KR,Misra P,Liu F,Mathur S,Lenkinski RE,Frangioni JV.Detection of breast cancer microcalcifications using a dual-modality SPECT/NIR fluorescent probe.J Am Chem Soc. 2008 Dec 31;130(52):17648-9.
  • Lenkinski RE,Bloch BN,Liu F,Frangioni JV,Perner S,Rubin MA,Genega EM,Rofsky NM,Gaston SM.An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer.MAGMA. 2008 Nov;21(6):411-21.
  • Frangioni JV.New technologies for human cancer imaging.J Clin Oncol. 2008 Aug 20;26(24):4012-21. Review.
  • Yuan TL,Choi HS,Matsui A,Benes C,Lifshits E,Luo J,Frangioni JV,Cantley LC.Class 1A PI3K regulates vessel integrity during development and tumorigenesis.Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9739-44.
  • Frangioni JV.The impact of greed on academic medicine and patient care.Nat Biotechnol. 2008 May;26(5):503-7. Review.
  • Knapp DW, Adams LG, Degrand AM, Niles JD, Ramos-Vara JA, Weil AB, O'Donnell MA, Lucroy MD, Frangioni JV.Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light.Eur Urol. 2007 Dec;52(6):1700-8.
  • Misra P, Humblet V, Pannier N, Maison W, Frangioni JV.Production of multimeric prostate-specific membrane antigen small-molecule radiotracers using a solid-phase 99mTc preloading strategy.J Nucl Med. 2007 Aug;48(8):1379-89.
  • Humblet V, Misra P, Frangioni JV.An HPLC/mass spectrometry platform for the development of multimodality contrast agents and targeted therapeutics: prostate-specific membrane antigen small molecule derivatives.Contrast Media Mol Imaging. 2006 Sep;1(5):196-211.
  • Parungo CP, Soybel DI, Colson YL, Kim SW, Ohnishi S, DeGrand AM, Laurence RG, Soltesz EG, Chen FY, Cohn LH, Bawendi MG, Frangioni JV.Lymphatic drainage of the peritoneal space: a pattern dependent on bowel lymphatics.Ann Surg Oncol. 2007 Feb;14(2):286-98.
  • Humblet V, Lapidus R, Williams LR, Tsukamoto T, Rojas C, Majer P, Hin B, Ohnishi S, De Grand AM, Zaheer A, Renze JT, Nakayama A, Slusher BS, Frangioni JV.High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen.Mol Imaging. 2005 Oct-Dec;4(4):448-62.
  • Parungo CP, Colson YL, Kim SW, Kim S, Cohn LH, Bawendi MG, Frangioni JV.Sentinel lymph node mapping of the pleural space.Chest. 2005 May;127(5):1799-804.
  • Parungo CP, Ohnishi S, Kim SW, Kim S, Laurence RG, Soltesz EG, Chen FY, Colson YL, Cohn LH, Bawendi MG, Frangioni JV.Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging.J Thorac Cardiovasc Surg. 2005 Apr;129(4):844-50.
  • Romeo G, Frangioni JV, Kazlauskas A.Profilin acts downstream of LDL to mediate diabetic endothelial cell dysfunction.FASEB J. 2004 Apr;18(6):725-7.
  • Cowley SM, Kang RS, Frangioni JV, Yada JJ, DeGrand AM, Radhakrishnan I, Eisenman RN.Functional Analysis of the Mad1-mSin3A Repressor-Corepressor Interaction Reveals Determinants of Specificity, Affinity, and Transcriptional Response.Mol Cell Biol. 2004 Apr 1;24(7):2698-2709.
  • Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG, Frangioni JV.Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping.Nat Biotechnol. 2004 Jan;22(1):93-7.
  • De Grand AM, Frangioni JV.An operational near-infrared fluorescence imaging system prototype for large animal surgery.Technol Cancer Res Treat. 2003 Dec;2(6):553-62.
  • Alves FC, Donato P, Sherry AD, Zaheer A, Zhang S, Lubag AJ, Merritt ME, Lenkinski RE, Frangioni JV, Neves M, Prata MI, Santos AC, de Lima JJ, Geraldes CF.Silencing of phosphonate-gadolinium magnetic resonance imaging contrast by hydroxyapatite binding.Invest Radiol. 2003 Dec;38(12):750-60.
  • Lenkinski RE, Ahmed M, Zaheer A, Frangioni JV, Goldberg SN.Near-infrared fluorescence imaging of microcalcification in an animal model of breast cancer.Acad Radiol. 2003 Oct;10(10):1159-64.
  • Frangioni JV.In vivo near-infrared fluorescence imaging.Curr Opin Chem Biol. 2003 Oct;7(5):626-34.
  • Maison W, Frangioni JV.Improved chemical strategies for the targeted therapy of cancer.Angew Chem Int Ed Engl. 2003 Oct 13;42(39):4726-8.
  • English JR, Accorsi R, Idoine JD, Parker JA, Renze JT, Lanza RC, Frangioni JV.Sub-millimeter technetium-99m calibration sources.Mol Imaging Biol. 2002 Oct;4(5):380-4.
  • Nakayama A, del Monte F, Hajjar RJ, Frangioni JV.Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy.Mol Imaging. 2002 Oct;1(4):365-77.
  • Nakayama A, Bianco AC, Zhang CY, Lowell BB, Frangioni JV.Quantitation of brown adipose tissue perfusion in transgenic mice using near-infrared fluorescence imaging.Mol Imaging. 2003 Jan;2(1):37-49.
  • Zaheer A, Wheat TE, Frangioni JV.IRDye78 conjugates for near-infrared fluorescence imaging.Mol Imaging. 2002 Oct;1(4):354-64.
  • Lim YT, Kim S, Nakayama A, Stott NE, Bawendi MG, Frangioni JV.Selection of quantum dot wavelengths for biomedical assays and imaging.Mol Imaging. 2003 Jan;2(1):50-64.
  • Voss SD, DeGrand AM, Romeo GR, Cantley LC, Frangioni JV.An integrated vector system for cellular studies of phage display-derived peptides.Anal Biochem. 2002 Sep 15;308(2):364-72.
  • Brunet A, Kanai F, Stehn J, Xu J, Sarbassova D, Frangioni JV, Dalal SN, DeCaprio JA, Greenberg ME, Yaffe MB.14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport.J Cell Biol. 2002 Mar 4;156(5):817-28.
  • Zaheer A, Lenkinski RE, Mahmood A, Jones AG, Cantley LC, Frangioni JV.In vivo near-infrared fluorescence imaging of osteoblastic activity.Nat Biotechnol. 2001 Dec;19(12):1148-54.
  • Frangioni JV, LaRiccia LM, Cantley LC, Montminy MR.Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening.Nat Biotechnol. 2000 Oct;18(10):1080-5.
  • Hausdorff SF, Frangioni JV, Birnbaum MJ.Role of p21ras in insulin-stimulated glucose transport in 3T3-L1 adipocytes.J Biol Chem. 1994 Aug 26;269(34):21391-4.
  • Frangioni JV, Moghal N, Stuart-Tilley A, Neel BG, Alper SL.The DNA binding domain of retinoic acid receptor beta is required for ligand-dependent suppression of proliferation. Application of general purpose mammalian coexpression vectors.J Cell Sci. 1994 Apr;107 ( Pt 4):827-38.
  • Frangioni JV, Oda A, Smith M, Salzman EW, Neel BG.Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets.EMBO J. 1993 Dec;12(12):4843-56.
  • Frangioni JV, Neel BG.Use of a general purpose mammalian expression vector for studying intracellular protein targeting: identification of critical residues in the nuclear lamin A/C nuclear localization signal.J Cell Sci. 1993 Jun;105 ( Pt 2):481-8.
  • Frangioni JV, Neel BG.Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins.Anal Biochem. 1993 Apr;210(1):179-87.
  • Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG.The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence.Cell. 1992 Feb 7;68(3):545-60.
  • Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ, Neel BG.High frequency of retinoic acid receptor beta abnormalities in human lung cancer.Oncogene. 1991 Oct;6(10):1859-68.
  • Ingber DE, Prusty D, Frangioni JV, Cragoe EJ, Lechene C, Schwartz MA.Control of intracellular pH and growth by fibronectin in capillary endothelial cells.J Cell Biol. 1990 May;110(5):1803-11.
  • Schwartz MA, Rupp EE, Frangioni JV, Lechene CP.Cytoplasmic pH and anchorage-independent growth induced by v-Ki-ras, v-src or polyoma middle T.Oncogene. 1990 Jan;5(1):55-8.
  • Frangioni JV, Kwan-Gett TS, Dobrunz LE, McMahon TA.The mechanism of low-frequency sound production in muscle.Biophys J. 1987 May;51(5):775-83.